progesterone

progesterone. It is a crucial steroid hormone belonging to the class of progestogens and is a key metabolic intermediate in the production of other endogenous steroids. Primarily secreted by the corpus luteum of the ovary and later by the placenta, it plays a central role in the menstrual cycle, pregnancy, and embryogenesis. Its functions extend to various other tissues, including the brain, breast, and bone.

Chemical structure and properties

Progesterone is a C21 steroid hormone, specifically a pregnane derivative, with a molecular formula of C₂₁H₃₀O₂. Its core structure consists of four fused cycloalkane rings, characteristic of all steroid molecules. The molecule contains two ketone groups, at the C3 and C20 positions, and a double bond between the C4 and C5 carbon atoms, classifying it as a Δ⁴-3-ketosteroid. This structure is synthesized from the precursor pregnenolone through the action of the enzyme 3β-hydroxysteroid dehydrogenase. Its lipophilic nature allows it to passively diffuse across cell membranes to bind to intracellular receptors. The crystalline form of progesterone was first characterized by researchers at the University of Rochester.

Biosynthesis and metabolism

The biosynthesis of progesterone occurs primarily in the ovary, specifically within the theca interna and granulosa cells of the corpus luteum, as well as in the adrenal cortex and, during gestation, the placenta. The initial substrate is cholesterol, which is transported into the mitochondria by the steroidogenic acute regulatory protein. The rate-limiting step involves the cleavage of the cholesterol side-chain by the CYP11A1 enzyme to form pregnenolone. Pregnenolone is then converted to progesterone by 3β-hydroxysteroid dehydrogenase. Metabolism occurs mainly in the liver, where it is reduced to inactive metabolites such as pregnanediol, which is conjugated with glucuronic acid and excreted by the kidney. The enterohepatic circulation can also play a role in its metabolic fate.

Physiological functions

Progesterone is indispensable for regulating the uterine endometrium, transforming it from a proliferative state to a secretory one to facilitate blastocyst implantation. It maintains pregnancy by suppressing myometrial contractility and maternal immune responses against the fetus. In the breast, it works in concert with estradiol to promote lobuloalveolar development during the luteal phase and pregnancy. Within the central nervous system, it exerts neuroprotective and neurosteroid effects, influencing GABAergic transmission via its metabolite allopregnanolone. It also affects body temperature, respiratory drive, and bone metabolism through interactions with the osteoblast and osteoclast systems.

Medical uses

Synthetic analogues, known as progestins, are widely used in hormonal therapies. In hormone replacement therapy, they are combined with estrogen to protect the endometrium from hyperplasia in postmenopausal women. They are a key component of combined oral contraceptive pills, where they inhibit ovulation and alter cervical mucus. Progesterone itself is used in assisted reproductive technologies like in vitro fertilization to support the luteal phase. It is also administered to prevent preterm birth in women with a history of premature delivery, as endorsed by the American College of Obstetricians and Gynecologists. Formulations include micronized progesterone, vaginal gels, and intramuscular injections.

Measurement and levels

Serum levels of progesterone are typically measured using immunoassay techniques, such as chemiluminescence or radioimmunoassay. Levels fluctuate dramatically throughout the menstrual cycle, with peak concentrations (>10 ng/mL) occurring during the mid-luteal phase, secreted by the corpus luteum. In pregnancy, the placenta takes over production, leading to a steady rise, often exceeding 100 ng/mL in the third trimester. Abnormally low levels can indicate luteal phase defect or ectopic pregnancy, while elevated levels may be seen in some adrenal tumors or congenital adrenal hyperplasia. The World Health Organization has established reference materials for assay standardization.

History and discovery

The discovery of progesterone is credited to multiple investigators in the early 20th century. In 1929, George Washington Corner and Willard Myron Allen at the University of Rochester demonstrated that extracts from the corpus luteum were necessary for maintaining pregnancy in rabbits; they named the active principle "progestin." The hormone was first isolated in pure, crystalline form in 1934 by Adolf Butenandt from the corpus luteum of pigs, and its structure was elucidated shortly thereafter. Butenandt, along with Leopold Ruzicka, later synthesized the hormone from stigmasterol, a plant sterol, for which they were awarded the Nobel Prize in Chemistry in 1939. The first total chemical synthesis was achieved by Robert Burns Woodward. Category:Steroid hormones Category:Progestogens Category:Sex hormones